These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10744007)

  • 21. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
    Tsouderos Y
    Z Kardiol; 1991; 80 Suppl 7():95-101. PubMed ID: 1792820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroven: not much effect in trials.
    Drug Ther Bull; 1992 Jan; 30(2):7-8. PubMed ID: 1555498
    [No Abstract]   [Full Text] [Related]  

  • 24. A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency.
    Guillot B; Guilhou JJ; de Champvallins M; Mallet C; Moccatti D; Pointel JP
    Int Angiol; 1989; 8(4 Suppl):67-71. PubMed ID: 2632651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From skin disorders to venous leg ulcers: pathophysiology and efficacy of Daflon 500 mg in ulcer healing.
    Coleridge Smith PD
    Angiology; 2003; 54 Suppl 1():S45-50. PubMed ID: 12934756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency.
    Aziz Z; Tang WL; Chong NJ; Tho LY
    J Clin Pharm Ther; 2015 Apr; 40(2):177-85. PubMed ID: 25630350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.
    Poynard T; Valterio C
    Vasa; 1994; 23(3):244-50. PubMed ID: 7975870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacology of the drugs prescribed for chronic venous diseases].
    Talibov OB
    Khirurgiia (Mosk); 2019; (2):106-109. PubMed ID: 30855600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
    Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
    Stemmer R; Furderer CR
    Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):205-12. PubMed ID: 16708123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 33. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary filtration and ankle edema in patients with venous hypertension: effects of Daflon.
    Cesarone MR; Laurora G; De Sanctis MT; Belcaro G
    Angiology; 1993 Jan; 44(1):57-61. PubMed ID: 8424585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New aspects in the pathogenesis of chronic venous insufficiency and the place of localized action of Venoruton].
    Bekers S; Zilstra I
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():28-32. PubMed ID: 19705689
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
    Wadworth AN; Faulds D
    Drugs; 1992 Dec; 44(6):1013-32. PubMed ID: 1282862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(18):409-12. PubMed ID: 9454438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous elasticity after treatment with Daflon 500 mg.
    Ibegbuna V; Nicolaides AN; Sowade O; Leon M; Geroulakos G
    Angiology; 1997 Jan; 48(1):45-9. PubMed ID: 8995343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency].
    Bisler H; Pfeifer R; Klüken N; Pauschinger P
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1321-9. PubMed ID: 3527643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.